Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Lynn Kirkpatrick
Person

Lynn Kirkpatrick

Tracked across 2 events · 12 articles · First seen Jun 26, 2026 · Last active Aug 20, 2026

Sentiment
35
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (2)
4 60
Tech
Ensysce Biosciences Initiates Opioid Study
Impact: Lynn Kirkpatrick, as CEO of Altor BioScience, provided key statements regarding the significance of the PF614-MPAR technology in addressing the opioid crisis and establishing a new standard for opioid safety.
Jun 26, 2026 · 6 articles
1 10
Tech
Ensysce Biosciences PAINWeek 2026 Symposium
Forte Biosciences, a clinical-stage biotechnology company, announced it will host an educational symposium at PAINWeek 2026 titled 'A New Era in Pain Therapeutics.' The symposium will showcase the company's neural reset strategy for its botanical…
Impact: As CEO, Lynn Kirkpatrick is a featured speaker and spokesperson, representing the company's leadership in the symposium.
Aug 20, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Lynn Kirkpatrick live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.